ALS patients exhibited greater levels of TCR expansions in CD4+ CTLs as well as in CD4+ and CD8+ T cells with an activated phenotype (CCR7−CCL5+), compared with controls (Fig. 4A, B). The gene discussed is CD4; the disease is amyotrophic lateral sclerosis.